Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study DOI Creative Commons
Blair Aitken, Luke A. Downey,

Serah Rose

et al.

Journal of Psychopharmacology, Journal Year: 2024, Volume and Issue: 38(11), P. 998 - 1006

Published: Oct. 11, 2024

Methylphenidate is a routinely prescribed treatment for attention-deficit/hyperactivity disorder with misuse potential owing to its perceived performance-enhancing and euphoric properties. Although clinically effective, there limited understanding of how methylphenidate affects safety-sensitive tasks such as driving when used by healthy individuals.

Language: Английский

The driving‐related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation DOI Creative Commons
Danielle McCartney, Cilla Zhou, Isobel Lavender

et al.

Drug and Alcohol Review, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 7, 2025

Abstract Introduction In January 2020, the government of Australian Capital Territory (ACT) decriminalised possession and cultivation cannabis for personal use. This study explored driving‐related attitudes, beliefs behaviours ACT residents who are legally cultivating consuming cannabis. Methods A two‐part cross‐sectional was conducted. Part‐1: Cannabis users residing in were invited to complete an online survey. Part‐2: Survey respondents reported ‘currently growing’ submit a sample their home‐grown phytocannabinoid analysis. Data from Parts 1 2 used estimate participants' usual Δ 9 ‐tetrahydrocannabinol (THC) intakes. Results N = 385 completed all or part survey 52 submitted samples Most participants ( 224/330; 67.9%) waiting ≥7 h following use before driving. However, 21.5% 71/330) ≤3 h. These individuals had highest THC intakes (where known). Further analyses revealed that expressed less concern about roadside drug testing effects non‐medicinal medicinal on driving, more frequently, larger amounts, exclusively purposes likely report shorter ‘wait times’. Discussion Conclusion small proportion appear be driving shortly (i.e., h) after considerable quantities THC. behaviour puts them at risk while impaired incurring legal sanctions. Interventions alerting these possible risks are, therefore, warranted.

Language: Английский

Citations

0
Attitudes toward driving after cannabis use: a systematic review DOI Creative Commons

Bianca Boicu,

Durr Al-Hakim,

Yue Yuan

et al.

Journal of Cannabis Research, Journal Year: 2024, Volume and Issue: 6(1)

Published: Sept. 28, 2024

Language: Английский

Citations

1
Response to ensuring safety in cannabinoid prescriptions: A call for critical assessment DOI
Brooke Manning, Amie C. Hayley, Luke A. Downey

et al.

European Neuropsychopharmacology, Journal Year: 2024, Volume and Issue: 88, P. 50 - 50

Published: Sept. 2, 2024

Language: Английский

Citations

0
Cannabis and Driving in Australia and Canada: Exploring Stakeholders' Perspectives to Help Inform Education Initiatives DOI Creative Commons

Estelle Pretorius

Published: Jan. 1, 2024

This research project explored the perspectives of stakeholders in Australia and Canada on cannabis use driving to help inform development educational initiatives. The prevalence after is rising world-wide. Harm reduction-based education with aim encouraging safer behaviours users becoming more important. In this project, individual interviews online surveys provided insight into current attitudes different groups effective

Language: Английский

Citations

0
Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study DOI Creative Commons
Blair Aitken, Luke A. Downey,

Serah Rose

et al.

Journal of Psychopharmacology, Journal Year: 2024, Volume and Issue: 38(11), P. 998 - 1006

Published: Oct. 11, 2024

Methylphenidate is a routinely prescribed treatment for attention-deficit/hyperactivity disorder with misuse potential owing to its perceived performance-enhancing and euphoric properties. Although clinically effective, there limited understanding of how methylphenidate affects safety-sensitive tasks such as driving when used by healthy individuals.

Language: Английский

Citations

0